Cytotoxic T cells are able to efficiently eliminate cancer cells by additive cytotoxicity

Nat Commun. 2021 Sep 1;12(1):5217. doi: 10.1038/s41467-021-25282-3.

Abstract

Lethal hit delivery by cytotoxic T lymphocytes (CTL) towards B lymphoma cells occurs as a binary, "yes/no" process. In non-hematologic solid tumors, however, CTL often fail to kill target cells during 1:1 conjugation. Here we describe a mechanism of "additive cytotoxicity" by which time-dependent integration of sublethal damage events, delivered by multiple CTL transiting between individual tumor cells, mediates effective elimination. Reversible sublethal damage includes perforin-dependent membrane pore formation, nuclear envelope rupture and DNA damage. Statistical modeling reveals that 3 serial hits delivered with decay intervals below 50 min discriminate between tumor cell death or survival after recovery. In live melanoma lesions in vivo, sublethal multi-hit delivery is most effective in interstitial tissue where high CTL densities and swarming support frequent serial CTL-tumor cell encounters. This identifies CTL-mediated cytotoxicity by multi-hit delivery as an incremental and tunable process, whereby accelerating damage magnitude and frequency may improve immune efficacy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / immunology
  • Cell Death
  • Cell Line, Tumor
  • Cytotoxicity, Immunologic*
  • DNA Damage
  • Female
  • Humans
  • Kinetics
  • MCF-7 Cells
  • Male
  • Melanoma / therapy*
  • Mice
  • Mice, Inbred C57BL
  • Perforin / genetics
  • Perforin / metabolism*
  • T-Lymphocytes, Cytotoxic / immunology*

Substances

  • PRF1 protein, human
  • Perforin